Psychedelics Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
16:11
Feb 04
Justin Mares Founder and CEO of Truemed a16z
Psychedelics underinvested, effective mental-health therapy
Psychedelics, especially ketamine-assisted therapy, are powerful mental-health interventions that work better than SSRIs in many cases, particularly treatment-resistant depression and PTSD. They have few side effects with doctor oversight, are vastly underinvested, and should be part of the treatment menu for veterans and others with intense depression.
HIGH

About Psychedelics Investor Commentary

Across the available history and selected sources, Buzzberg tracks Psychedelics across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Justin Mares.